Hyderabad, Aug 7: Yashoda Hospitals, Hitec City has successfully performed a complex double lung transplant on a 47-year-old patient diagnosed with Anti-synthetase Syndrome-associated Fibrotic Interstitial Lung Disease, offering him a new lease on life after two years of oxygen dependence. The successful procedure further strengthens the hospital’s position as a leading centre for advanced lung transplant surgery in Hyderabad and the management of complex end-stage lung diseases.
The patient had been living with progressive fibrotic ILD, a condition that causes irreversible scarring of the lungs, leading to severe respiratory failure. Despite receiving optimal medical treatment, his lung function continued to decline, leaving him dependent on long-term oxygen therapy. Following a comprehensive evaluation, a bilateral lung transplant was identified as the only definitive treatment to restore his breathing and quality of life.
The transplant was successfully carried out by a multidisciplinary team led by Dr. V. Nagarjuna Maturu, Clinical Director, Department of Pulmonology, along with Dr. Manjunath Bale, Lung Transplant Surgeon, Dr. Vikram Reddy, Consultant Cardiothoracic and Vascular Surgeon , Dr. Battu Chaithanya, Transplant Pulmonologist, and Dr. Sushanth Panda, Transplant Anaesthetist. The patient’s perioperative and postoperative care was overseen by the Critical Care team under Dr. Ravi Shankar, with invaluable support from transplant nurses, physiotherapists, dietitians, and transplant coordinators.
The surgery was completed successfully without any intraoperative or postoperative complications. Following the transplant, the patient was gradually weaned off oxygen support, regained functional independence, and was able to walk comfortably before discharge. His remarkable recovery enabled him to return home just 10 days after the procedure.
Speaking on the successful transplant, Dr. V. Nagarjuna Maturu, Clinical Director, Department of Pulmonology, Yashoda Hospitals, Hitec City, said:
“Patients with Anti-synthetase Syndrome-associated Fibrotic Interstitial Lung Disease often experience relentless progression of lung fibrosis, eventually leading to end-stage respiratory failure. For carefully selected patients, lung transplantation offers the opportunity to breathe independently again and regain a meaningful quality of life. This successful outcome highlights the importance of early referral, timely evaluation, meticulous patient selection, and coordinated multidisciplinary care. Witnessing the patient walk independently and breathe without oxygen within days of surgery is truly rewarding for the entire team.”
Dr. Manjunath Bale, Lung Transplant Surgeon, Yashoda Hospitals, Hitec City, added:
“Double lung transplantation is one of the most complex procedures in thoracic surgery and demands exceptional coordination across multiple specialties. Every stage—from donor lung retrieval and transplantation to critical care and rehabilitation—requires seamless teamwork. This successful case reflects the expertise, planning, and commitment of our multidisciplinary transplant program, enabling patients with advanced lung disease to return to active and independent lives.”
The patient’s rapid recovery demonstrates the strength of Yashoda Hospitals’ comprehensive lung transplant program, which combines advanced surgical expertise with evidence-based critical care, structured pulmonary rehabilitation, nutritional support, and vigilant post-transplant monitoring to optimise long-term outcomes.
Beyond its technical success, this transplant represents a profound transformation in the patient’s life. After spending nearly two years dependent on supplemental oxygen and limited by severe breathlessness, he is now breathing independently, walking without oxygen support, and looking forward to resuming his daily activities.
With a dedicated multidisciplinary transplant team, advanced infrastructure, and internationally aligned treatment protocols, Yashoda Hospitals, Hitec City continues to deliver world-class care for patients with advanced respiratory diseases requiring lung transplantation, reaffirming its commitment to clinical excellence, innovation, and patient-centred care.